| CASE REPORT |
|
| Year : 2018 | Volume
: 1
| Issue : 2 | Page : 97-100 |
|
|
Prolonged survival with anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: A case series
Pratik Patil, Vineet G Gupta, Ranga R Rangaraju, Waseem Abbas, Peush Bajpai
Department of Medical Oncology, Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India
Correspondence Address:
Vineet G Gupta
Department of Medical Oncology, B-2 Basement, Max Super Speciality Hospital, Shalimar Bagh, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | 30 |
DOI: 10.4103/JCO.JCO_22_18
|
|
|
Head and neck cancer (HNC) is the sixth most common cancer worldwide, with approximately 650,000 patients newly diagnosed annually. In the late 1990s, surgery followed by postoperative radiotherapy (RT) or RT alone was the standard therapeutic modality for locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC). As chemotherapeutic agents were identified to have additional effects when combined with RT, chemoradiotherapy has become the standard treatment over the last decade for patients with LA-HNSCC who were not candidates for surgery. Despite the heterogeneity of both tumor location and genetic aberrations, 90% of HNCs are histologically squamous cell carcinomas. Hereby, we present a case series of patients with HNSCC who were benefited with anti-epidermal growth factor receptor therapy with a prolonged survival. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
